Thyroid Cancer | Tumor

CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.

Dwyane Wade Talks Tumor Removal, Bachelorette Star’s Husband Cancer Diagnosis and More

January 31st 2025, 4:00pm

Article

From the reveal of NBA star Dwyane Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is this week’s top cancer news.

How a Singer-Songwriter’s Cancer History Can Be Heard in Her Music

December 3rd 2024, 4:00pm

Article

Singer-songwriter Danielia Cotton, a thyroid cancer survivor and marathon runner shared how her experiences impact her art.

Oncology Drugs Approved by the FDA in September 2024

October 1st 2024, 3:00pm

Article

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer.

FDA Approves Retevmo for Some With Medullary Thyroid Cancer

September 27th 2024, 7:48pm

Article

The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer.

Study Confirms Lenvima’s Benefits in Thyroid Cancer

September 19th 2024, 9:00pm

Article

First-time treatment with Lenvima continues to outperform other treatments for thyroid cancer.

Managing Quality of Life After Iodine Treatment for Thyroid Cancer

August 7th 2024, 3:00pm

Video

Interventions, such as speech therapy, after receiving radioactive iodine treatment for thyroid cancer may help manage quality of life.

FDA Approvals for Solid Cancers in June

July 1st 2024, 7:00pm

Article

The Food and Drug Administration issued six approvals for solid tumors in June, including thyroid, endometrial, colorectal, breast and ovarian cancers.

Retevmo Approval the Beginning of Targeted Therapy for RET-Mutant Childhood Cancer

June 25th 2024, 3:00pm

Article

An expert discusses the recent approval for Retevmo for RET-positive pediatric thyroid cancer and ongoing research for this patient population.

FDA Approves Retevmo for Some Adults and Children With Thyroid Cancer

June 12th 2024, 7:00pm

Article

The Food and Drug Administration granted a traditional approval to Retevmo for adult and pediatric patients 2 years old and older with advanced or metastatic RET fusion-positive thyroid cancer.

FDA Approves Retevmo for RET-Positive Pediatric Cancers

May 29th 2024, 4:41pm

Article

Retevmo was approved for childhood metastatic medullary thyroid, thyroid and solid tumors with RET mutations or gene fusions.